from Stocks-Markets-Economic Times https://ift.tt/3iubfjH
Home »
Stocks-Markets-Economic Times
» AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 cr
AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 cr
from Stocks-Markets-Economic Times https://ift.tt/3iubfjH
Related Posts:
ET Market Watch: Nifty, Sensex end flat amid profit booking in heavyweights from Stocks-Markets-Economic Times https://ift.tt/QYSDrbT … Read More
Coforge acquires 17% stake in Cigniti Technologies for Rs 645 croreA total of 46.18 lakh shares of Cigniti were sold by Kukunuru Madhava Lakshmi, Kukunuru Kumar Bapuji, Sapna and Chakkilam at the same price. Shares of Cigniti Technologies fell 1.28 per cent to close at Rs 1,367.20 per piece … Read More
Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in Mankind PharmaThrough the stake sale, Canada Pension Plan took home about Rs 256 crore. At the end of March quarter, it held 1.47% equity in the company. In separate deals, Capital group affiliate Hema CIPEF has sold 0.46% stake in Mankind… Read More
Block Deals: Mankind Pharma to see stake sale worth Rs 763 cr; Canada Pension Plan may sell 3.17% in DelhiveryHema CIPEF is selling 37 lakh shares (0.9% of its total equity) at a discounted price of Rs 2,061 per share, 2% below the current market value. As of the end of March, Hema CIPEF, a fund mostly owned by the company's promoter… Read More
AI boom reshapes Wall Street as TSMC joins trillion-dollar clubThe entry of Taiwanese chip giant TSMC into the elite club of the world's most valuable companies is further proof that the generative AI revolution is shaking up Wall Street. The top ten of the world's most valuable companie… Read More
0 Comments:
Post a Comment